secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001558370-23-018328
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Q3 revenue down 21% to $2.2M; announces $8M cost cuts for 2024
----------------------------------------------------------------------

- Revenue $2.2M in Q3 2023, down from $2.8M in Q3 2022; nine-month revenue $6.7M, down 17%.
- Gross profit margin fell to 59.8% from 75.1% in Q3; non-GAAP adjusted EBITDA loss improved to $2.9M from $4.2M.
- Cash $1.5M at Sept 30; raised $2.8M net in Oct public offering; no debt.
- Targeting ~$8M cost reductions in 2024 including RIF, aiming >40% cut in operating expenses.
- Exclusive license deal with Biorad for Obalon in India subcontinent; FDA decision on Lap-Band 2.0 Flex expected by year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837023018328/0001558370-23-018328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837023018328/rsls-20231108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-018328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer